Compare, Analyse Torrent Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-18
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,550348-   
Low Rs1,144251-   
Sales per share (Unadj.) Rs354.7103.5-  
Earnings per share (Unadj.) Rs40.1-26.1-  
Cash flow per share (Unadj.) Rs64.2-21.6-  
Dividends per share (Unadj.) Rs14.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs273.181.3-  
Shares outstanding (eoy) m169.22168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.82.9 131.2%   
Avg P/E ratio x33.6-11.5 -292.7%  
P/CF ratio (eoy) x21.0-13.9 -151.3%  
Price / Book Value ratio x4.93.7 133.8%  
Dividend payout %34.90-   
Avg Mkt Cap Rs m227,89750,553 450.8%   
No. of employees `00014.74.3 342.4%   
Total wages/salary Rs m11,3533,173 357.8%   
Avg. sales/employee Rs Th4,083.04,069.9 100.3%   
Avg. wages/employee Rs Th772.3739.1 104.5%   
Avg. net profit/employee Rs Th461.3-1,025.5 -45.0%   
INCOME DATA
Net Sales Rs m60,02117,472 343.5%  
Other income Rs m2,988122 2,442.5%   
Total revenues Rs m63,00917,594 358.1%   
Gross profit Rs m13,493-3,028 -445.6%  
Depreciation Rs m4,086754 541.9%   
Interest Rs m3,085473 651.8%   
Profit before tax Rs m9,310-4,133 -225.3%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,529258 979.2%   
Profit after tax Rs m6,781-4,403 -154.0%  
Gross profit margin %22.5-17.3 -129.7%  
Effective tax rate %27.2-6.2 -434.7%   
Net profit margin %11.3-25.2 -44.8%  
BALANCE SHEET DATA
Current assets Rs m52,62312,797 411.2%   
Current liabilities Rs m52,0227,200 722.5%   
Net working cap to sales %1.032.0 3.1%  
Current ratio x1.01.8 56.9%  
Inventory Days Days120111 107.8%  
Debtors Days Days76124 61.5%  
Net fixed assets Rs m85,0167,459 1,139.7%   
Share capital Rs m84681 1,043.1%   
"Free" reserves Rs m45,3760-   
Net worth Rs m46,22213,714 337.1%   
Long term debt Rs m41,1154,819 853.1%   
Total assets Rs m142,43225,906 549.8%  
Interest coverage x4.0-7.7 -52.0%   
Debt to equity ratio x0.90.4 253.1%  
Sales to assets ratio x0.40.7 62.5%   
Return on assets %6.9-15.2 -45.7%  
Return on equity %14.7-32.1 -45.7%  
Return on capital %14.2-19.8 -71.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,9800-   
CASH FLOW
From Operations Rs m8,9421,491 599.6%  
From Investments Rs m-47,070-458 10,279.0%  
From Financial Activity Rs m34,1744,374 781.3%  
Net Cashflow Rs m-3,6555,407 -67.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.8 Rs / ZAR

Compare TORRENT PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: FDC LTD.  BIOCON   WYETH LTD  DISHMAN PHARMA  IPCA LABS  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Oct 18, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS